Skip to content
Screener

Total Revenue at other companies

3M logo
3MMMM
$6.5B+2.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$22K-97.0%
Biogen logo
BiogenBIIB
$2.74B+3.4%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$83.22M+18.9%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$1.68B+4.3%
Entegris logo
EntegrisENTG
$811.9M+5.0%

Segments

By segment

See full
Advanced Electronics Solutions$117.5M
Elastomeric Material Solutions$94.8M+6.0%
Other$4.5M+2.3%

By geography

See full
China$69.3M
United States$55.8M
Germany$21.1M

Other financials

Income statement

See full
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Net sales$216.8$202.8$417.3$393.3
Cost of sales146.4138.8282.3272.3
Gross margin70.464.0135.0121.0
Selling, general and administrative expenses42.248.583.493.0
Research and development expenses7.37.014.014.1
Restructuring and impairment charges0.776.16.682.0
Other operating (income) expense, net0.2(0.1)0.3(0.3)
Operating income (loss)20.0(67.5)30.7(67.8)

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's total revenue?
Rogers Corporation (ROG) reported total revenue of $216.8M in Q2 2026.
How has Rogers Corporation's total revenue changed year-over-year?
Rogers Corporation's total revenue increased by 6.9% year-over-year, from $202.8M to $216.8M.
What is the long-term trend for Rogers Corporation's total revenue?
Over 4 years (2021 to 2025), Rogers Corporation's total revenue has grown at a -3.4% compound annual growth rate (CAGR), from $932.89M to $810.8M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Rogers Corporation's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude